Skip to Search Skip to Main Content Skip to Footer

User Login

Administration Login

RESEARCH

Powered by EBSCO
Menu
  • Back to COVID-19 Information Portal
  • Open Access Resources

RSS Feed

Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Health Effects of Involuntary Displacement of Homeless Individuals Who Inject Drugs
Study Provides New Insight Into Female Sex Hormones and Migraines
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Warns Consumers to Not Purchase or Use Nose Slap and Soul Slap Products Marketed for Alertness and Energy Boosting
FDA Approves Lumryz (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy
FDA Approves Lumryz (sodium oxybate) for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy

Pages

  • « first
  • ‹ previous
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • next ›
  • last »

back to top

Workflow: 
Published
   

<none> Powered By EBSCO Stacks 3.3.0 [350.1p] | Administration Login

GDPR | Privacy Policy | EBSCO Connect

© 2019 EBSCO - All Right Reserved.